877-295-0886

Board of Directors

Contact Us

Leadership and oversight from a strong, ROI-focused team

Board of Directors


Frank Murphy, President, CEO & Chairman of the Board of Directors
Allen Moseley, General Partner
Robert L. Crutchfield, Venture Partner
Paul D. Taylor, M.D., Chief Medical Information Officer
Mason Beard, VP, Product Development


Frank Murphy

President, CEO & Chairman of the Board of Directors

Frank MurphyFrank Murphy was appointed president, CEO, and Chairman of the Board of Directors of WellCentive, Inc. in June 2011. In that role he is responsible for the strategic vision, sales and marketing, operations, and overall execution for the company. He comes to the company with nearly 30 years of healthcare IT experience.

Prior to joining WellCentive, Murphy served as president and chief executive officer of Perimeter Health Advisors, LLC, a boutique M&A advisory firm.  From 2004 to 2008, he served as president and CEO of HealthPort Technologies, a healthcare software and technology enabled services firm.  Prior to that, he served as president of the Physician Services Division at Per-Se Technologies, Inc., a publicly traded business management outsourcing company and the largest physician revenue cycle services provider in the U.S. Per-Se was acquired by McKesson (NYSE:MCK) in 2007.

Earlier in his career, Murphy spent many years at Hospital Corp. of America (HCA), where he began his extensive and prestigious healthcare career. At HCA, he was president and chief executive officer of two regional medical centers and a three hospital healthcare system operating under the company’s umbrella.

Murphy currently serves on the Board of Directors of MedData, one of the nation’s leading providers of revenue cycle services for hospital-based physicians.

Mr. Murphy attended Duke University in Durham, N.C., where he received his undergraduate degree, and his MHA from the Fuqua School of Business.

[Back to list]


Allen Moseley

General Partner  

Allen MoseleyAllen Moseley joined Noro-Moseley Partners (NMP) in 1998 and leads the firm’s healthcare practice, focused primarily in healthcare services, healthcare information technology and medical devices.  In addition to WellCentive, he currently represents NMP on the boards of Diabetes Care Group, Navitas Lease Finance, RemitDATA, Renal CarePartners, Senior Whole Health, and Valor Healthcare.  Allen also oversees the firm’s investment in Direct Insurance and Lanx.  Allen was previously a director or observer for several prior NMP investments, including Apex Analytix (sold to PNC Equity), Bloodhound Technologies (sold to Verisk Analytics), U.S. Radiosurgery (sold to Alliance Imaging) and Witness Systems (IPO, sold to Verint Systems).

Prior to joining NMP in 1998, Allen was in the corporate finance group at The Robinson-Humphrey Company, an investment banking firm previously owned by Citigroup and most recently acquired by SunTrust.  Allen worked extensively in the healthcare and business services industries, advising on a number of initial public offerings, M&A transactions and private placements.  He was also involved in R-H Capital Partners, the private equity investment arm of the firm.  Previously, Allen held investment banking positions with Bowles Hollowell Conner & Company and Merrill Lynch & Co.

Allen was recently Chairman of Venture Atlanta and Chairman of the Technology Association of Georgia, the state’s largest entrepreneur-focused organization. He has also served on the board of North Carolina’s Council for Entrepreneurial Development, one of the largest entrepreneur organizations in the country. Allen is also a member of the Nashville Healthcare Council. Allen received a BA from the University of North Carolina at Chapel Hill, where he was a member of Phi Beta Kappa, and an MBA from Harvard Business School.

[Back to list]


Robert L. Crutchfield

Venture Partner

Robert C. CrutchfieldBob Crutchfield is a Venture Partner in the General Partner at Harbert Management Corporation (HMC).  Mr. Crutchfield joined HMC in September 2008 and serves as a Board Member of Optimal and as a board observer for Aldagen, Innovative Biosensors, MaxCyte and ControlScan.  In addition to his responsibilities at HMC, he serves as the Chairman of the Commercialization Sub-Committee for the Alabama Innovation Council Study Commission, serves on the Steering Committee of the Alabama Obesity Institute at the University of Alabama in Birmingham, is a Venture Fellow at the University of Alabama in Tuscaloosa, is a Visiting Executive at Auburn University, and is a member of the Board of Directors for the Southeast Medical Device Association, the Birmingham Venture Club, the Alabama Launch Pad, and the Atlanta Venture Forum.  Mr. Crutchfield also serves as a member of the Investment Advisory Board for the Florida Institute for the Commercialization of Public Research.

Prior to joining Harbert Venture Partners, Mr. Crutchfield served as Senior Vice President/General Manager of the Pharmacy Services Division at U.S. Oncology, a privately held, vertically integrated cancer care provider network with cancer clinics in more than 440 sites of service and a physician network consisting of over 1,000 medical oncologists and radiation oncologists.  His division was responsible for approximately $2 billion of annual revenue, and under his leadership the division’s EBITDA grew to over $80 million.  Mr. Crutchfield was also a Senior Executive at CardinalHealth, where he served as Vice President of New Ventures.  While with Cardinal Health, he built and launched a new surgical products business unit through licensing of new technologies, acquisitions and creating a new North American sales channel.  In 1995, Mr. Crutchfield founded Surgical Innovations and Services, Inc. (SIS), a surgical laser management company.  Under his leadership, SIS became a leader in the emerging outsource management sector, with over 300 hospitals and surgery centers under contract with SIS for management oversight and delivery of their surgical laser programs.  In 2000, SIS merged with Surgical Laser Technologies, Inc. (SLTI) a publicly traded surgical laser-manufacturing firm.  Mr. Crutchfield continued as President of SIS and served as VP of Sales, Marketing and Business Development for SLTI, until he exited the company following its acquisition by publicly-traded Photomedex, Inc.

Mr. Crutchfield has launched five successful new business ventures during his private and corporate career and has led four M&A transactions. He is a graduate of the University of Georgia and holds Bachelor of Science degrees in Political Science and Chemistry.

[Back to list]


Paul D. Taylor, M.D.

Chief Medical Information Officer

Dr. Paul D. Taylor, MDDr. Taylor is a co-founder of WellCentive and a practicing internal medicine physician, with experience building and implementing clinical quality improvement systems of care at the physician practice, physician organization, and regional levels.

Dr. Taylor is an established expert in clinical quality improvement.  He is the current chair of the Clinical Integration and Oversight Committee for the Lakeshore Health Network physician organization, a leader in Michigan for clinical quality improvement programs, which is consistently ranked in the state’s top three physician organizations.  He has served on the Executive Committee and Finance and Operations Committee for the Primary Care Network for Trinity Health – Mercy Health Partners, as well as a quality improvement workgroup for a regional Robert Wood Johnson Foundation-funded health information exchange project.

Dr. Taylor graduated from the University of Michigan Medical School, and completed his residency training at the University of Michigan Hospitals. He is Board Certified in Internal Medicine.

[Back to list]


Mason Beard

VP, Product Development

Mason BeardMr. Beard is a co-founder of WellCentive, with experience designing and implementing flagship medical software systems.

Previously, he was a clinical application designer for Patient Care Technologies, a MEDITECH company (the oldest software company in the U.S.), where he developed a rules-based, task-oriented healthcare application for optimizing workflow in the home care setting. This industry-leading product helped MEDITECH retain clients and capture more of its target market.

He designed WellCentive’s software application suite and oversees the company’s development team and all technical operations.

Mr. Beard earned a B.S. in Occupational Therapy from Concordia University, Wisconsin and an M.A. in Health Studies/Health Promotion from the University of Alabama.

[Back to list]